Advertisements

Fenistil Hydrocort

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Fenistil Hydrocort

Property Description
Active Ingredient Hydrocortisone (INN)
Form Cream (Creme), Topical
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Use Relief of localized skin inflammation and itching
Origin Synthetic derivative of cortisol

What Type of Medicine Is Fenistil Hydrocort?

Fenistil Hydrocort is fundamentally a widely recognized topical pharmaceutical preparation containing the active ingredient, Hydrocortisone (INN: Hydrocortisonum). It is formally classified as a Glucocorticoid within the broader category of Corticosteroids, meaning its core substance is a steroid medicine developed as a synthetic derivative of the naturally occurring human hormone cortisol. This product is typically presented as a monopreparation, featuring this single anti-inflammatory substance designed exclusively for the topical route of administration.

Fenistil Hydrocort is often positioned in the non-prescription market for common, localized skin issues, such as managing mild irritation from insect bites or minor rashes. Hydrocortisone serves as a mild-acting surface treatment in these contexts.

Composition, Form, and General Purpose

The formulation is characteristically provided as a cream (Creme), which is an emulsion base optimized for ease of spreading and local absorption into the skin surface. This vehicle facilitates the effective delivery of the active ingredient.

The general therapeutic purpose of the preparation is to provide targeted, localized relief from the primary symptoms of skin irritation. Its action is characterized by a triple effect: providing anti-pruritic action (relieving the discomfort of itching), facilitating anti-inflammatory action (reducing swelling and warmth), and exerting a vasoconstrictive action (diminishing redness). These combined effects allow the preparation to generally help soothe the irritated skin.

Is Hydrocortisone a Mild or Strong Steroid?

Hydrocortisone, the active component of Fenistil Hydrocort, is a low-potency or mild steroid. This classification is a critical differentiator, making it suitable for managing mild to moderate surface irritations.

The low-potency nature of hydrocortisone dictates that its therapeutic effect is primarily localized and suitable for managing temporary, uncomplicated skin issues, which supports its frequent use in non-prescription preparations.

Regulatory References

  1. Hydrocortisone Topical Label Information (DailyMed/NIH)
  2. Hydrocortisone Topical (MedlinePlus Drug Information)
Advertisements

What side effects are possible with Fenistil Hydrocort?

Possible side effects and safety information

Fenistil Hydrocort contains hydrocortisone, a mild corticosteroid. The documented safety profile covers local skin reactions, systemic risks from absorption, and specific restrictions on use.


Adverse Reactions (Side Effects)

Adverse reactions are primarily localized to the application site. Common or less frequent local effects may include:

  • Skin and Subcutaneous Tissue Disorders: Burning, irritation, dryness, or stinging sensation at the application site. Other documented effects are thinning of the skin (skin atrophy), visible small blood vessels, changes in skin color (lightening or darkening), and the appearance of stretch marks (striae).

Systemic Risks

Systemic effects are rare but are linked to the potential for the active ingredient to be absorbed into the body, especially with prolonged use, application to large surface areas, or application under occlusive dressings (like bandages or tight-fitting diapers). These systemic effects can include:

  • Endocrine Disorders: Suppression of the hypothalamic-pituitary-adrenal (HPA) axis, which may manifest as symptoms of Cushing's syndrome or adrenal suppression.
  • Ophthalmic Disorders: Prolonged use near the eyes has been associated with the risk of developing cataracts or glaucoma.

Safety-Related Restrictions and Limitations

Official regulatory documents define specific contraindications and situations requiring caution:

  • Contraindications: This medicine is officially restricted from use in the presence of certain untreated skin infections (e.g., viral infections like cold sores/herpes, fungal, or bacterial infections), perioral dermatitis, rosacea, or acne.
  • Population and Area Restrictions: Particular caution is required when using the product on the face or in skin folds (intertriginous areas). Use in infants and young children requires extra vigilance due to their increased susceptibility to systemic absorption and HPA-axis suppression.
  • Exposure-Related Patterns: Risks such as skin atrophy and systemic effects are officially associated with long-term use, and therefore treatment duration is limited to mitigate these documented safety patterns.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for topical hydrocortisone overdose centers on the risk of systemic absorption, which can occur with excessive or prolonged use, particularly over large skin areas or under occlusive dressings. This systemic effect may lead to reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and clinical presentations documented as manifestations of Cushing's syndrome. Specific signs of systemic toxicity listed in regulatory documents include hyperglycemia and glucosuria.

Required Emergency Actions

Patients receiving long-term or widespread application are required to undergo periodic evaluation for HPA axis suppression, often utilizing the ACTH stimulation test. Immediate medical attention may be necessary if symptoms of steroid withdrawal occur upon discontinuing the product, as these symptoms may require administration of supplemental systemic corticosteroids. While no specific antidote is known, treatment is generally symptomatic and supportive, focusing on reducing or withdrawing the product.

Population-Specific Considerations

Regulatory authorities note that pediatric patients have greater susceptibility to systemic toxicity due to their body surface area to weight ratio. Severe outcomes documented in children include intracranial hypertension, as well as signs of adrenal suppression such as delayed weight gain and linear growth retardation.

Advertisements

Therapeutic Uses of Fenistil Hydrocort

Fenistil Hydrocort is commonly used to help provide symptomatic relief for conditions involving inflammatory or irritative states across several common, mild dermatological conditions. It is relevant in clinical settings that involve acute or unstable symptom patterns, where short-term symptomatic assistance is appropriate.

Hydrocortisone topical is used to help treat redness, swelling, itching, and discomfort of various skin conditions.

The cream is considered relevant for the symptomatic management of conditions such as mild forms of eczema and contact dermatitis, as well as common reactions like localized inflammation from insect bites and superficial sunburn. This medication contributes to symptomatic relief by easing the overall symptom burden and may assist with reducing the visible manifestations of inflammation.

Symptomatic Relief and Therapeutic Domains

This medication is applied in domains involving symptoms related to heightened physiological activity, primarily to moderate the intensity of pronounced, acute itching and accompanying burning sensations. By contributing to the easing of these symptoms, the cream may assist with maintaining functional stability and helps patients cope more steadily during periods of heightened symptomatic discomfort.


Quick Fact: Relief for Acute Localized Itching Fenistil Hydrocort is commonly used to help provide symptomatic relief in situations where symptoms related to localized pruritus create noticeable functional strain.

Regulatory References

  1. MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Fenistil Hydrocort's eligibility profile strictly follows regulatory guidelines, defining who is allowed to use the product and who is absolutely restricted.

Contraindicated Populations (Must Not Use)

Use of this medication is contraindicated if the patient has a documented hypersensitivity to the ingredients or if the skin issue is caused by an untreated skin infection (viral, fungal, or bacterial). Contraindication also applies to specific inflammatory skin conditions, including rosacea, acne vulgaris, perioral dermatitis, and ulcerative conditions.

Age and Conditional Use

Age-related eligibility limits standard use to adults and children aged two years and older. The cream is not recommended for children under two years without medical advice. For all children, use is restricted to a maximum of seven days to mitigate the risk of systemic absorption, and use under a diaper is cautioned against.

Specific Restrictions

Regarding pregnancy and lactation, official labeling indicates inadequate evidence of safety during pregnancy, requiring use to be subject to a medical benefit-risk assessment. During breastfeeding, the product must not be applied to the chest area. Finally, caution is required for patients with pre-existing systemic conditions such as diabetes or Cushing's syndrome.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fenistil Hydrocort, which contains low-potency Hydrocortisone for topical use, has an officially documented interaction profile focused primarily on localized and additive systemic effects, rather than conventional drug-drug interactions (DDIs) involving metabolic enzymes.

Due to minimal systemic absorption during standard use, regulatory documents generally do not list formal constraints concerning systemic medications, alcohol, food, or herbal products.

Pharmacodynamic and Administration Constraints

Category Regulatory Statement Summary
Other Topical Products Co-application of other skin preparations to the treated area should be avoided to prevent potential dilution of the active ingredient and altered absorption.
Other Steroids Concurrent use with other topical or systemic corticosteroid medicines may result in an additive systemic corticosteroid exposure, increasing the overall potential for systemic effects like HPA axis suppression.
Procedural Restrictions The use of occlusive dressings, including tight-fitting diapers or plastic pants over the application site, is restricted because it is documented to substantially increase the percutaneous absorption of the Hydrocortisone.

Population-Specific Interaction Notes

Official labeling notes that pediatric patients (infants and children) may exhibit a greater susceptibility to systemic absorption. This higher rate of absorption, linked to a greater skin surface area-to-body mass ratio, elevates the theoretical potential for systemic effects and interactions compared to adult populations. This caution governs the context under which any systemic DDI might become relevant.

Advertisements

Mechanism of Action

Fenistil Hydrocort contains hydrocortisone, a lipophilic glucocorticoid. Upon topical application, hydrocortisone crosses the cellular membrane of target cells, such as immune and inflammatory cells, to bind to the cytosolic glucocorticoid receptor ( GR). This binding event acts as an agonist, inducing a conformational change in the receptor protein. The activated hydrocortisone-GR complex then translocates into the cell nucleus.

Within the nucleus, the complex modulates gene transcription via two primary molecular pathways: transactivation and transrepression.

Transactivation involves the complex binding to specific Glucocorticoid Response Elements ( GREs) in the promoter regions of targeted genes, leading to the upregulation of anti-inflammatory proteins, notably Annexin A1 (Lipocortin-1). Annexin A1 subsequently inhibits phospholipase A2, which reduces the release of arachidonic acid from membrane phospholipids, thus decreasing the synthesis of downstream eicosanoids like prostaglandins and leukotrienes.

Transrepression involves protein-protein interactions where the GR complex directly interferes with the activity of pro-inflammatory transcription factors, such as NF-kappa B and AP-1. This interference prevents the transcription of genes encoding various pro-inflammatory cytokines ( IL-1, IL-6, TNF-alpha) and key inflammatory enzymes like cyclooxygenase-2 ( COX-2) and inducible nitric oxide synthase ( iNOS). The net system-level physiological consequence of these actions is a localized reduction in vascular permeability, inhibition of immune cell migration to the site of application, and a suppression of the cellular inflammatory signaling cascade.

Advertisements

Dosage and Administration Information

Fenistil Hydrocort is designed for topical administration only, meaning it is to be applied exclusively to the surface of the skin. Application involves using only a thin film or small quantity sufficient to cover the affected area. The cream is rubbed in gently to ensure proper use.

The standard frequency of administration for adults and children six years and older begins with application once or twice daily, a regimen commonly used at the start of treatment. As the localized condition is managed, the frequency of use is typically adjusted to once daily. The total treatment duration should not exceed two consecutive weeks without explicit professional advice.

The cream must not be used on large areas, which is defined as more than 10% of the body surface area, nor should it be applied to sensitive sites such as the eyes or mucous membranes. The treated skin area must not be covered with occlusive materials, such as bandages or tight dressings, unless such an application is explicitly prescribed. After administration, the hands are to be washed thoroughly, unless the hands are the specific site being treated.

Usage for children under six years of age is subject to stricter limitations: application is typically restricted to once per day and requires medical supervision and prescription, further defining the boundaries of use for this population.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fenistil Hydrocort

Evidence related to short-term changes in Skin Inflammation and Itching Caused by Minor Eczema

This section will summarize the research studies and clinical trials that have investigated Fenistil Hydrocort exploring patterns related to changes in symptoms like redness, swelling, and itching associated with mild eczema (atopic dermatitis). The focus will be on patterns observed regarding short-term changes in these minor symptoms.

Research has studied Fenistil Hydrocort in people experiencing mild, non-severe forms of eczema, which are conditions characterized by fluctuating or episodic manifestations. These studies often monitored short-term changes in outcomes linked to inflammatory or irritative states. The evidence contributes to understanding symptom patterns and suggests that research reports on short-term symptom changes.


Evidence related to patterns observed in Mild Sunburn and Insect Bites

This part will outline the available evidence regarding the use of Fenistil Hydrocort in research exploring temporary changes in the mild inflammation, pain, and irritation resulting from uncomplicated sunburn and non-venomous insect bites. Studies report how symptoms evolved in the observed populations, and the data show patterns related to temporary changes in redness and itching that often follows a mild exposure or bite.

This evidence is derived from studies assessing short-term or episodic symptom patterns, particularly for conditions involving periods of heightened symptoms in a small skin area.


Long-Term Studies and Follow-up

The majority of studies involving Fenistil Hydrocort research explored short-term symptom changes over defined time intervals. For use beyond short, intermittent periods, evidence is limited, and long-term effects are not fully established. The data for extended use or long-term follow-up are still emerging, meaning the certainty remains low regarding the patterns observed when the cream was used consistently over long periods.


What is Still Uncertain About Fenistil Hydrocort

The main evidence gaps relate to the long-term use of the cream, as follow-up durations were limited. Comparative evidence is lacking regarding how Fenistil Hydrocort compares directly to every available alternative across all outcomes related to physical discomfort. Furthermore, subgroup findings are uncertain for several special populations, meaning more dedicated research is ongoing to fully contextualize the available data.

Key Studies & References

  1. Label: HYDROCORTISONE cream (Topical Hydrocortisone 0.5% OTC Drug Facts) - DailyMed (NIH)
  2. Eczema: Steroids and other topical medications - InformedHealth.org (NCBI/IQWiG)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fenistil Hydrocort (FAQ)

Q: Why is hydrocortisone used in a cream format?

Hydrocortisone is formulated as a topical cream specifically for cutaneous use, meaning it is intended only for application on the skin’s surface. This method allows the active ingredient to be absorbed locally by the affected area, enabling it to act directly on inflammation while limiting the amount absorbed into the body.

Q: Is Fenistil Hydrocort available over the counter, or does it need a prescription?

The availability of Fenistil Hydrocort depends on its strength and local regulatory rules. According to official classification, certain low strengths (such as 1% hydrocortisone) may be available over-the-counter for specific uses. Formulations with higher concentrations generally require a prescription.

Q: Can children of all ages use Fenistil Hydrocort?

Regulatory guidelines state that the use of the cream in children is subject to restrictions based on age. Official guidance often recommends limiting the duration of treatment, and in many regions, the product is strongly discouraged or contraindicated for use in children under 2 years of age without a healthcare professional’s guidance.

Q: Is it okay to use Fenistil Hydrocort with other topical creams, like a moisturizer?

Official guidance often warns against using occlusive dressings (like bandages) over the treated area, as this can increase absorption. Regarding non-occlusive products like moisturizers, consult the specific product labeling for guidance on timing and concurrent use. Observing increased dryness is noted in regulatory documents as a potential local side effect.

Q: Can Fenistil Hydrocort be applied to the face?

Application to the face should be avoided or severely restricted. The skin on the face is thinner and more sensitive, which increases the potential for systemic absorption and the risk of adverse effects like skin thinning. Official labeling typically prohibits or severely restricts application to the face due to increased absorption risks.

Q: Why might a doctor prescribe Fenistil Hydrocort?

Official labeling describes the cream as being indicated for the temporary management of symptoms associated with various inflammatory skin conditions. This typically includes minor irritant and allergic dermatitis, reactions to insect bites, and mild to moderate forms of eczema.

Q: What are the general contraindications (reasons not to use) for Fenistil Hydrocort?

The product is generally contraindicated if a person is known to be allergic to hydrocortisone or any of the inactive ingredients (excipients). It is also typically contraindicated for use on skin with active, untreated bacterial, viral (e.g., cold sores), or fungal infections, as the steroid component can worsen or mask the infection.

Q: Can using Fenistil Hydrocort affect the results of skin allergy tests?

As a glucocorticoid, hydrocortisone has strong anti-inflammatory and immunosuppressive properties. Because of this mechanism, applying the cream to the area being tested may potentially interfere with the results of diagnostic skin tests. Information regarding potential interference should be discussed with a healthcare provider or testing facility before using the cream prior to such diagnostic procedures.

Q: What are the risks of using Fenistil Hydrocort near the eyes?

Official warnings state that the cream must not be used on the eyes or mucous membranes. Systemic absorption near the eye carries specific risks, including potential issues related to increased intraocular pressure (glaucoma) or the development of cataracts.

Q: Is the antihistamine ingredient in regular Fenistil also in Fenistil Hydrocort?

No, these are different products. Fenistil Hydrocort contains hydrocortisone as its only active ingredient. Official labeling for Fenistil Hydrocort does not typically include the antihistamine compound (dimetindene maleate) found in products marketed as 'regular Fenistil' gel or drops.

Q: Is Fenistil Hydrocort the same as regular Fenistil?

No, the two products contain different active ingredients and work in different ways. Fenistil Hydrocort contains the steroid hydrocortisone, which works to reduce inflammation. Products marketed as 'regular Fenistil' typically contain an antihistamine to block allergic reactions and relieve itching.

Q: Can Fenistil Hydrocort be used on insect bites?

Yes, regulatory documents often list insect bite reactions as an official therapeutic indication for hydrocortisone-containing creams. The indication for this use is based on the cream's anti-inflammatory properties, which target the symptoms associated with the bite.

Q: How long does it usually take to feel an effect after applying Fenistil Hydrocort?

While regulatory texts often do not provide precise onset-of-action data, clinical studies on topical hydrocortisone products suggest that a noticeable reduction in symptoms like itching and redness can often be observed within 24 hours of beginning therapy.

Q: What should I do if I forget to apply the cream?

Regulatory documents describe the procedure for a missed dose, generally stating that one should resume the schedule if remembered soon after the missed time. If it is almost time for your next scheduled dose, you should skip the missed dose and simply continue with your regular schedule.

Q: Are there different strengths of Fenistil Hydrocort available?

Yes, hydrocortisone-based topical products are generally available in a range of strengths, commonly including 0.5% and 1% concentrations. The strength available depends on the specific product formulation and the local regulatory approvals in your region.

Q: Are there any common side effects people report when using this cream?

According to official product information, common local side effects include temporary skin irritation, dryness, burning, or itching. More serious effects, such as irreversible skin thinning (atrophy), are possible, particularly with prolonged use or use under occlusion.

Q: What are the signs of an allergic reaction to Fenistil Hydrocort?

Signs of a serious allergic reaction may include sudden and severe swelling of the face, lips, tongue, or throat, known as angioedema. The appearance of a widespread, severe skin rash (hives) accompanied by difficulty breathing also constitutes a serious reaction noted in patient information.

Q: Can Fenistil Hydrocort make skin dryness worse?

Yes, official regulatory documents list skin dryness as a reported local side effect of topical corticosteroids. Observing increased dryness is noted in regulatory documents as a potential local side effect.

Q: Has Fenistil Hydrocort been studied for use during pregnancy?

Regulatory guidance often states that there is inadequate evidence of safety regarding the use of topical corticosteroids in human pregnancy. For this reason, use during pregnancy is typically considered only after a medical professional has carefully weighed the potential risks and benefits.

Q: Are there restrictions on using Fenistil Hydrocort while breastfeeding?

Yes, there are restrictions. While systemic absorption is generally minimal, the cream should not be applied to the breasts or nipples to prevent the accidental oral ingestion of the medicine by the infant during feeding.

Q: Does alcohol consumption impact the use of Fenistil Hydrocort?

Official regulatory summaries generally do not document any specific, known interactions between the topical use of hydrocortisone and the consumption of alcohol. This is primarily due to the very low amount of the medication that is typically absorbed into the bloodstream.

Q: What types of medications are known to potentially interact with Fenistil Hydrocort?

Due to the minimal topical absorption with correct use, clinically significant drug-drug interactions are rare. However, if the cream is used extensively on large areas or for long periods, theoretical interactions possible with systemic corticosteroids (such as with certain antifungals) may be considered.

Q: What should be done if too much cream is applied?

Regulatory documents state that if excessive amounts of the cream are applied topically, treatment is usually symptomatic. If a large quantity is accidentally swallowed, symptoms may include nausea, vomiting, and diarrhea. In such cases, obtaining professional medical advice is generally recommended.

Q: Is there any research evidence supporting the use of Fenistil Hydrocort for eczema?

Yes. Hydrocortisone cream is a standard, officially indicated treatment for various inflammatory dermatoses, including mild to moderate eczema. The evidence indicates that its anti-inflammatory properties are consistent with its use for the symptomatic management of mild to moderate eczema.

Q: Can exposure to sunlight change how Fenistil Hydrocort works?

Yes. Warnings in regulatory documents advise users to avoid prolonged exposure to the sun on extensively treated areas of skin. Topical corticosteroids may potentially increase the skin's sensitivity to light.

Q: Are there any specific safety warnings related to using Fenistil Hydrocort on open skin?

Yes, official warnings exist. The use of Fenistil Hydrocort on broken or eroded skin is generally restricted or contraindicated. This is because damaged skin can significantly increase the systemic absorption of hydrocortisone, raising the risk of systemic side effects.

Q: What is the difference between Fenistil Hydrocort cream and ointment?

The key difference is in the formulation and base ingredients. Creams have a lighter, water-based foundation, while ointments are typically greasier (often containing paraffin or oil). Ointments are generally used for very dry or thickened skin, while creams are used for weeping or less dry areas.

Q: Is Fenistil Hydrocort known to cause skin thinning with short-term use?

Skin thinning, or atrophy, is a known potential adverse effect of topical corticosteroids. Regulatory information suggests this is primarily associated with prolonged use, use on sensitive areas like the face, or use under occlusion, rather than with appropriate short-term use of a low-potency steroid.

Q: Can Fenistil Hydrocort be used on areas with a skin infection?

No. The cream is generally contraindicated for use on skin that has an active, untreated bacterial, viral (e.g., herpes simplex), or fungal infection. The corticosteroid component can reduce the body's natural inflammatory response, potentially allowing the infection to worsen or spread.

Q: Is Fenistil Hydrocort associated with rebound effects when stopped?

Official warnings note that long-term, continuous use of topical steroids can lead to the development of rebound flares, sometimes referred to as Topical Steroid Withdrawal Syndrome, when treatment is abruptly stopped. Regulatory documents indicate that this risk is greater following prolonged continuous use.

Q: Do older adults need different considerations when using Fenistil Hydrocort?

Official documentation for topical corticosteroids generally does not specify unique dosing guidelines for the elderly population. However, caution is typically advised because older adults naturally have thinner skin, which could potentially increase the risk of side effects from absorption.

Q: Are there reports of Fenistil Hydrocort affecting blood pressure?

Since the cream is for local application, the risk of systemic effects like changes in blood pressure is considered low with correct use. However, high blood pressure is a known potential serious effect associated with corticosteroids when they are absorbed in significant amounts into the body.

Q: Is it true that corticosteroids like Fenistil Hydrocort can affect blood sugar levels?

High blood sugar is a known systemic effect of corticosteroids. While the risk is very low with appropriate topical use, regulatory documents advise caution for individuals with diabetes if the cream is used extensively or for long periods, due to potential systemic absorption.

Q: What are the general guidelines for storing Fenistil Hydrocort cream?

Specific storage guidelines are provided on the product packaging and in the patient leaflet to maintain the product's stability. These typically advise storing the cream below a certain temperature (e.g., 25 C) or at controlled room temperature, and keeping the product out of the reach of children.

Q: Can Fenistil Hydrocort be used for rashes caused by plants, like poison ivy?

Yes. Topical hydrocortisone is officially indicated for treating the symptoms of contact allergic dermatitis, which includes the inflammatory rashes caused by plants such as poison ivy. The cream helps reduce the swelling and itching associated with this type of reaction.

Q: Does Fenistil Hydrocort contain any known allergens or preservatives?

Yes, like all medicines, the cream contains inactive ingredients called excipients to form the base and maintain stability. These typically include preservatives, such as chlorocresol, which can, in rare cases, cause local skin reactions. The full list is detailed in the official patient information leaflet.

Q: Are there official patient leaflets available for Fenistil Hydrocort online?

Yes. As a regulated medicinal product, the official Summary of Product Characteristics (SmPC) and the Patient Information Leaflet (PIL) are typically made publicly available by the government or intergovernmental regulatory authorities (e.g., FDA, EMA, MHRA).

Q: What are the main findings from clinical trials on Fenistil Hydrocort?

The clinical trials and regulatory assessment reports confirm that hydrocortisone is a mild and effective corticosteroid for its primary purpose. The main findings support its anti-inflammatory properties and its ability to provide symptomatic relief for officially indicated skin conditions.

Q: What are the typical ingredients other than the active one in Fenistil Hydrocort?

Other than the active ingredient hydrocortisone, the cream contains various excipients (inactive ingredients). These generally include a combination of water, different types of paraffin, stabilizing agents, and preservatives required to form the cream's base.

Advertisements

How should Fenistil Hydrocort be stored and disposed of?

How to Store and Dispose of Fenistil Hydrocort (Hydrocortisone Topical)

Fenistil Hydrocort must be stored according to official regulatory requirements to ensure product stability and safety.

Storage Requirements

Requirement Type Official Condition
Temperature Store at Controlled Room Temperature (20 C to 25 C); Do not freeze.
Protection Store away from excess heat, moisture, and direct light.
Container Rule Keep in the original container and ensure it is tightly closed.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Fenistil Hydrocort must not be kept. The official instruction is to ask a pharmacist or healthcare professional how to dispose of any medicine that is no longer needed. This protocol avoids disposal through standard household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fenistil Hydrocort found in:

A-Z Index: